SEGMENT INFORMATION

6 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

SEGMENT INFORMATION

6. SEGMENT INFORMATION

We operate in two principal segments - research services and research products. Our Service segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Product segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to the Consolidated Financial Statements in our annual report on Form 10-K for the year ended September 30, 2015.

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2016		2015		2016		2015
Revenue:
Service	$	4,053	$	4,530	$	8,108	$	8,928
Product		1,286		1,196		2,126		2,643
	$	5,339	$	5,726	$	10,234	$	11,571
Operating income (loss):
Service	$	(279)	$	60	$	(598)	$	81
Product		17		(32)		(193)		89
	$	(262)	$	28	$	(791)	$	170
Interest expense		(70)		(75)		(136)		(156)
Change in fair value of warrant liability – decrease		79		199		168		319
Other income (expense)		—		(1)		1		1
Income (loss) before income taxes	$	(253)	$	151	$	(758)	$	334